A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 5, 2002, Pages 393-400

  Morant, S V ^a,b,c   Shield, Michael J ^b   Davey, P G ^a   MacDonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Pharmacia Corporation   (United Kingdom)

^c Cygnus Biostatistics Ltd   (United Kingdom)

Author keywords

Costs; Diclofenac; Hospitalization; Misoprostol diclofenac; NSAID; Pharmacoeconomics; Ulcer healing drugs

Indexed keywords

ANTIULCER AGENT; ARTHROTEC; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; DATA BASE; DIGESTIVE SYSTEM ULCER; DRUG COST; DRUG EXPOSURE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL MODEL; TABLET FORMULATION; ULCER HEALING; UNITED KINGDOM;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; COHORT STUDIES; DICLOFENAC; DRUG COMBINATIONS; ECONOMICS, PHARMACEUTICAL; HOSPITALIZATION; HUMANS; MIDDLE AGED; MISOPROSTOL; PEPTIC ULCER; SCOTLAND;

EID: 0036635245     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.724     Document Type: Article

References (27)

1. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer
2. Non-steroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly
3. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding
4. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin and corticosteroids
5. Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
6. Major upper gastrointestinal tract bleeding
7. Toward an epidemiology of gastropathy associated with non-steroidal anti-inflammatory drug use
8. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: A controlled study using record linkage in Tayside
9. Non-steroidal anti-inflammatory drug use and increased risk of peptic ulcer disease in elderly persons
10. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs
11. Variability in the risk of major gastrointestinal complications from non-aspirin, non-steroidal anti-inflammatory drugs
12. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
13. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
14. Variability in the risk of gastrointestinal complications with different non-steroidal anti-inflammatory drugs
15. Clinical economics review: Gastrointestinal complications of non-steroidal anti-inflammatory drugs
16. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use
17. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs
18. The Tayside medicines monitoring unit (MEMO)
19. An audit of the accuracy of upper gastrointestinal diagnoses in Scottish Morbidity Record 1 data in Tayside
20. Misclassification and selection bias in case-control studies using an automated database
21. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
22. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
23. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
24. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis